Due to the need for once-daily injections with liraglutide and the decreased effectiveness compared to semaglutide we have opted not to offer liraglutide at this time
Singh M, Mansuri MS, Kadam A, Palit SP, Dwivedi M, Laddha NC, et al
This helps you and your GP understand your "normal" levels
These sources were used to collect prescription volume statistics, regulatory approval data, clinical safety and efficacy studies from landmark trials (SUSTAIN, STEP, SELECT), epidemiological data on diabetes and obesity prevalence, pricing and reimbursement landscapes, and competitive intelligence for injectable versus oral semaglutide formulations, as well as emerging GLP-1 receptor agonist therapies